Black Diamond Therapeutics Inc (BDTX)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-03-20 | 2025-03-19 | S Sale | Large shareholder |
500,000
-15.5%
2.12USD 1,058,450 |
500,000 -15.5% | 2.12 | USD 1,058,450 | |
| 2025-03-20 | 2025-03-19 | S Sale | Large shareholder |
584,292
-15.3%
1.95USD 1,141,239 |
584,292 -15.3% | 1.95 | USD 1,141,239 | |
| 2025-03-20 | 2025-03-19 | S Sale | Large shareholder |
400,000
-9.5%
2.09USD 837,160 |
400,000 -9.5% | 2.09 | USD 837,160 | |
| 2025-03-20 | 2025-03-19 | S Sale | Large shareholder |
2,000,000
-32.2%
2.00USD 4,000,800 |
2,000,000 -32.2% | 2.00 | USD 4,000,800 | |
| 2025-03-20 | 2025-03-19 | S Sale | Large shareholder |
1,000,000
-13.9%
2.31USD 2,308,100 |
1,000,000 -13.9% | 2.31 | USD 2,308,100 | |
| 2025-03-20 | 2025-03-19 | S Sale | Large shareholder |
300,000
-4.0%
1.94USD 582,900 |
300,000 -4.0% | 1.94 | USD 582,900 | |
| 2025-03-20 | 2025-03-19 | S Sale | Large shareholder |
1,000,000
-11.7%
2.07USD 2,069,100 |
1,000,000 -11.7% | 2.07 | USD 2,069,100 | |
| 2024-08-30 | 2024-08-28 | S Sale |
Versant Venture Capital VI, L.P. Large shareholder |
221,600
-5.6%
6.32USD 1,400,556 |
221,600 -5.6% | 6.32 | USD 1,400,556 | |
| 2023-10-19 | 2023-10-17 | B Purchase | Large shareholder |
400,000
+4.9%
2.34USD 934,080 |
400,000 +4.9% | 2.34 | USD 934,080 | |
| 2023-07-07 | 2023-07-05 | B Purchase | Non-Executive Director |
935,850
+41.1%
5.00USD 4,679,250 |
935,850 +41.1% | 5.00 | USD 4,679,250 | |
| 2023-07-06 | 2023-07-05 | B Purchase | Non-Executive Director |
1,000,000
+29.0%
5.00USD 5,000,000 |
1,000,000 +29.0% | 5.00 | USD 5,000,000 | |
| 2023-07-03 | 2023-06-30 | B Purchase | Large shareholder |
1,000,000
+14.0%
5.00USD 5,000,000 |
1,000,000 +14.0% | 5.00 | USD 5,000,000 | |
| 2023-06-29 | 2023-06-27 | B Purchase | Large shareholder |
1,740,000
+32.4%
5.49USD 9,555,036 |
1,740,000 +32.4% | 5.49 | USD 9,555,036 | |
| 2023-06-28 | 2023-06-27 | PS Planned sale |
SEE REMARKS Executive Director |
25,000
-3.6%
6.70USD 167,500 |
25,000 -3.6% | 6.70 | USD 167,500 | |
| 2022-12-23 | 2022-12-22 | B Purchase |
SEE REMARKS Officer |
36,363
+40.8%
1.28USD 46,596 |
36,363 +40.8% | 1.28 | USD 46,596 | |
| 2022-12-23 | 2022-12-21 | B Purchase |
SEE REMARKS Officer |
20,000
+29.0%
1.29USD 25,770 |
20,000 +29.0% | 1.29 | USD 25,770 | |
| 2022-11-02 | 2022-10-31 | B Purchase | Large shareholder |
99,801
+1.9%
2.25USD 224,912 |
99,801 +1.9% | 2.25 | USD 224,912 | |
| 2022-10-31 | 2022-10-28 | B Purchase | Large shareholder |
172,974
+3.4%
2.18USD 376,962 |
172,974 +3.4% | 2.18 | USD 376,962 | |
| 2022-10-31 | 2022-10-27 | B Purchase | Large shareholder |
191,678
+3.9%
1.87USD 359,224 |
191,678 +3.9% | 1.87 | USD 359,224 | |
| 2022-10-25 | 2022-10-21 | B Purchase | Large shareholder |
87,850
+1.8%
1.51USD 132,750 |
87,850 +1.8% | 1.51 | USD 132,750 | |
| 2022-10-21 | 2022-10-20 | B Purchase | Large shareholder |
53,734
+1.1%
1.42USD 76,345 |
53,734 +1.1% | 1.42 | USD 76,345 | |
| 2022-10-21 | 2022-10-19 | B Purchase | Large shareholder |
77,689
+1.7%
1.32USD 102,775 |
77,689 +1.7% | 1.32 | USD 102,775 | |
| 2022-04-29 | 2022-04-28 | B Purchase | Large shareholder |
255,711
+5.8%
2.57USD 657,868 |
255,711 +5.8% | 2.57 | USD 657,868 | |
| 2022-04-29 | 2022-04-27 | B Purchase | Large shareholder |
150,000
+3.5%
2.66USD 399,480 |
150,000 +3.5% | 2.66 | USD 399,480 | |
| 2022-04-20 | 2022-04-19 | B Purchase | Large shareholder |
150,000
+3.6%
3.24USD 486,645 |
150,000 +3.6% | 3.24 | USD 486,645 | |
| 2022-04-20 | 2022-04-18 | B Purchase | Large shareholder |
150,000
+3.8%
3.29USD 493,935 |
150,000 +3.8% | 3.29 | USD 493,935 | |
| 2022-04-14 | 2022-04-13 | B Purchase | Large shareholder |
102,556
+2.6%
3.57USD 366,217 |
102,556 +2.6% | 3.57 | USD 366,217 | |
| 2022-04-14 | 2022-04-12 | B Purchase | Large shareholder |
150,000
+4.0%
3.42USD 513,600 |
150,000 +4.0% | 3.42 | USD 513,600 | |
| 2021-05-05 | 2021-05-03 | PS Planned sale |
Chief Scientific Officer Officer |
2,500
-43.9%
26.64USD 66,602 |
2,500 -43.9% | 26.64 | USD 66,602 | |
| 2021-04-13 | 2021-04-12 | PS Planned sale |
See Remarks Officer |
4,078
-32.7%
25.00USD 101,950 |
4,078 -32.7% | 25.00 | USD 101,950 | |
| 2021-04-07 | 2021-04-05 | PS Planned sale |
Chief Scientific Officer Officer |
2,500
-43.9%
25.54USD 63,848 |
2,500 -43.9% | 25.54 | USD 63,848 | |
| 2021-03-16 | 2021-03-12 | PS Planned sale |
See Remarks Officer |
4,078
-32.7%
26.36USD 107,493 |
4,078 -32.7% | 26.36 | USD 107,493 | |
| 2021-03-04 | 2021-03-03 | PS Planned sale |
Chief Scientific Officer Officer |
884
-21.6%
26.57USD 23,484 |
884 -21.6% | 26.57 | USD 23,484 | |
| 2021-03-04 | 2021-03-03 | PS Planned sale |
Chief Scientific Officer Officer |
1,616
-28.4%
25.85USD 41,778 |
1,616 -28.4% | 25.85 | USD 41,778 | |
| 2021-02-12 | 2021-02-12 | PS Planned sale |
See Remarks Officer |
307
-3.5%
27.66USD 8,492 |
307 -3.5% | 27.66 | USD 8,492 | |
| 2021-02-12 | 2021-02-12 | PS Planned sale |
See Remarks Officer |
3,771
-30.2%
27.19USD 102,533 |
3,771 -30.2% | 27.19 | USD 102,533 | |
| 2021-02-04 | 2021-02-03 | PS Planned sale |
Chief Scientific Officer Officer |
2,500
-43.9%
25.35USD 63,375 |
2,500 -43.9% | 25.35 | USD 63,375 | |
| 2021-01-14 | 2021-01-12 | PS Planned sale |
See Remarks Officer |
7,511
-47.2%
36.00USD 270,395 |
7,511 -47.2% | 36.00 | USD 270,395 | |
| 2021-01-14 | 2021-01-12 | PS Planned sale |
See Remarks Officer |
100
-0.6%
34.13USD 3,413 |
100 -0.6% | 34.13 | USD 3,413 | |
| 2021-01-14 | 2021-01-12 | PS Planned sale |
See Remarks Officer |
103
-0.6%
32.50USD 3,347 |
103 -0.6% | 32.50 | USD 3,347 | |
| 2021-01-14 | 2021-01-12 | PS Planned sale |
See Remarks Officer |
147
-0.9%
31.91USD 4,690 |
147 -0.9% | 31.91 | USD 4,690 | |
| 2021-01-14 | 2021-01-12 | PS Planned sale |
See Remarks Officer |
1,669
-9.3%
30.50USD 50,912 |
1,669 -9.3% | 30.50 | USD 50,912 | |
| 2021-01-14 | 2021-01-12 | PS Planned sale |
See Remarks Officer |
2,048
-10.3%
29.92USD 61,284 |
2,048 -10.3% | 29.92 | USD 61,284 | |
| 2021-01-11 | 2021-01-08 | PS Planned sale |
Chief Financial Officer Officer |
3,000
-100.0%
33.94USD 101,820 |
3,000 -100.0% | 33.94 | USD 101,820 | |
| 2021-01-06 | 2021-01-04 | PS Planned sale |
Chief Scientific Officer Officer |
537
-14.4%
31.78USD 17,065 |
537 -14.4% | 31.78 | USD 17,065 | |
| 2021-01-06 | 2021-01-04 | PS Planned sale |
Chief Scientific Officer Officer |
1,963
-34.4%
31.31USD 61,460 |
1,963 -34.4% | 31.31 | USD 61,460 | |
| 2021-01-06 | 2021-01-04 | PS Planned sale |
See Remarks Executive Director |
2,015
-0.3%
31.80USD 64,075 |
2,015 -0.3% | 31.80 | USD 64,075 | |
| 2021-01-06 | 2021-01-04 | PS Planned sale |
See Remarks Executive Director |
9,985
-1.4%
30.99USD 309,430 |
9,985 -1.4% | 30.99 | USD 309,430 | |
| 2020-12-16 | 2020-12-14 | PS Planned sale |
See Remarks Officer |
4,078
-57.6%
34.95USD 142,522 |
4,078 -57.6% | 34.95 | USD 142,522 | |
| 2020-12-10 | 2020-12-08 | PS Planned sale |
Chief Financial Officer Officer |
1,941
-100.0%
34.05USD 66,094 |
1,941 -100.0% | 34.05 | USD 66,094 | |
| 2020-12-10 | 2020-12-08 | PS Planned sale |
Chief Financial Officer Officer |
1,059
-35.3%
33.27USD 35,233 |
1,059 -35.3% | 33.27 | USD 35,233 | |
| 2020-12-04 | 2020-12-03 | PS Planned sale |
Chief Scientific Officer Officer |
2,500
-100.0%
32.42USD 81,055 |
2,500 -100.0% | 32.42 | USD 81,055 | |
| 2020-12-03 | 2020-12-01 | PS Planned sale |
See Remarks Executive Director |
1,077
-0.2%
33.45USD 36,021 |
1,077 -0.2% | 33.45 | USD 36,021 | |
| 2020-12-03 | 2020-12-01 | PS Planned sale |
See Remarks Executive Director |
10,923
-1.5%
32.64USD 356,553 |
10,923 -1.5% | 32.64 | USD 356,553 | |
| 2020-12-01 | 2020-11-30 | PS Planned sale | Non-Executive Director Large shareholder |
200
-0.0%
34.16USD 6,833 |
200 -0.0% | 34.16 | USD 6,833 | |
| 2020-12-01 | 2020-11-30 | PS Planned sale | Non-Executive Director Large shareholder |
10,193
-1.2%
33.13USD 337,680 |
10,193 -1.2% | 33.13 | USD 337,680 | |
| 2020-12-01 | 2020-11-30 | PS Planned sale |
Versant Venture Capital VI, L.P. Large shareholder |
200
-0.0%
34.16USD 6,833 |
200 -0.0% | 34.16 | USD 6,833 | |
| 2020-12-01 | 2020-11-30 | PS Planned sale |
Versant Venture Capital VI, L.P. Large shareholder |
10,193
-1.2%
33.13USD 337,680 |
10,193 -1.2% | 33.13 | USD 337,680 | |
| 2020-11-23 | 2020-11-19 | PS Planned sale |
Versant Venture Capital VI, L.P. Large shareholder |
114,854
-2.3%
33.01USD 3,791,331 |
114,854 -2.3% | 33.01 | USD 3,791,331 | |
| 2020-11-23 | 2020-11-19 | PS Planned sale | Non-Executive Director Large shareholder |
114,854
-2.3%
33.01USD 3,791,331 |
114,854 -2.3% | 33.01 | USD 3,791,331 | |
| 2020-11-23 | 2020-11-19 | PS Planned sale | Non-Executive Director Large shareholder |
15,163
-1.5%
33.01USD 500,531 |
15,163 -1.5% | 33.01 | USD 500,531 | |
| 2020-11-23 | 2020-11-19 | PS Planned sale |
Versant Venture Capital VI, L.P. Large shareholder |
15,163
-1.5%
33.01USD 500,531 |
15,163 -1.5% | 33.01 | USD 500,531 | |
| 2020-11-19 | 2020-11-18 | PS Planned sale |
Versant Venture Capital VI, L.P. Large shareholder |
473
-0.0%
33.09USD 15,653 |
473 -0.0% | 33.09 | USD 15,653 | |
| 2020-11-19 | 2020-11-18 | PS Planned sale |
Versant Venture Capital VI, L.P. Large shareholder |
63
-0.0%
33.09USD 2,085 |
63 -0.0% | 33.09 | USD 2,085 | |
| 2020-11-19 | 2020-11-18 | PS Planned sale | Non-Executive Director Large shareholder |
473
-0.0%
33.09USD 15,653 |
473 -0.0% | 33.09 | USD 15,653 | |
| 2020-11-19 | 2020-11-18 | PS Planned sale | Non-Executive Director Large shareholder |
63
-0.0%
33.09USD 2,085 |
63 -0.0% | 33.09 | USD 2,085 | |
| 2020-11-19 | 2020-11-17 | PS Planned sale |
Versant Venture Capital VI, L.P. Large shareholder |
3,705
-0.1%
33.05USD 122,450 |
3,705 -0.1% | 33.05 | USD 122,450 | |
| 2020-11-19 | 2020-11-17 | PS Planned sale | Non-Executive Director Large shareholder |
3,705
-0.1%
33.05USD 122,450 |
3,705 -0.1% | 33.05 | USD 122,450 | |
| 2020-11-19 | 2020-11-17 | PS Planned sale | Non-Executive Director Large shareholder |
489
-0.0%
33.05USD 16,161 |
489 -0.0% | 33.05 | USD 16,161 | |
| 2020-11-19 | 2020-11-17 | PS Planned sale |
Versant Venture Capital VI, L.P. Large shareholder |
489
-0.0%
33.05USD 16,161 |
489 -0.0% | 33.05 | USD 16,161 | |
| 2020-11-17 | 2020-11-16 | PS Planned sale |
Versant Venture Capital VI, L.P. Large shareholder |
177
-0.0%
33.01USD 5,843 |
177 -0.0% | 33.01 | USD 5,843 | |
| 2020-11-17 | 2020-11-16 | PS Planned sale |
Versant Venture Capital VI, L.P. Large shareholder |
23
-0.0%
33.01USD 759 |
23 -0.0% | 33.01 | USD 759 | |
| 2020-11-17 | 2020-11-16 | PS Planned sale | Non-Executive Director Large shareholder |
177
-0.0%
33.01USD 5,843 |
177 -0.0% | 33.01 | USD 5,843 | |
| 2020-11-17 | 2020-11-16 | PS Planned sale | Non-Executive Director Large shareholder |
23
-0.0%
33.01USD 759 |
23 -0.0% | 33.01 | USD 759 | |
| 2020-11-17 | 2020-11-13 | PS Planned sale |
Versant Venture Capital VI, L.P. Large shareholder |
1,502
-0.0%
34.53USD 51,865 |
1,502 -0.0% | 34.53 | USD 51,865 |